Glycated albumin is set lower in relation to plasma glucose levels in patients with Cushing's syndrome

Clinica Chimica Acta

Volumn 424, Issue , 2013, Pages 164-167

  Kitamura, Tetsuhiro ^a   Otsuki, Michio ^a   Tamada, Daisuke ^a   Tabuchi, Yukiko ^a   Mukai, Kosuke ^a   Morita, Shinya ^b   Kasayama, Soji ^b   Shimomura, Iichiro ^a   Koga, Masafumi ^c  

^a OSAKA UNIVERSITY   (Japan)

^b Department of Cardiology   (Japan)

^c KAWASAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Cushing's syndrome; Glucocorticoid; Glycated albumin; HbA1c; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

ADULT; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SELF MONITORING; SEX DIFFERENCE;

CUSHING'S SYNDROME; GLUCOCORTICOID; GLYCATED ALBUMIN; HBA1C; TYPE 2 DIABETES MELLITUS;

ADULT; BLOOD GLUCOSE; CUSHING SYNDROME; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOCORTICOIDS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; LINEAR MODELS; MALE; MIDDLE AGED; SERUM ALBUMIN;

EID: 84880252087     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.06.011     Document Type: Article

References (28)

1. Cohen M.P. Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy?. J Diabet Complications 1988, 2:214-217.
2. Koenig R.J., Peterson C.M., Jones R.L., Saudek C., Lehrman M., Cerami A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 1976, 295:417-420.
3. Bunn H.F., Gabbay K.H., Gallop P.M. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978, 200:21-27.
4. Jeffcoate S.L. Diabetes control and complications: the role of glycated haemoglobin, 25years on. Diabet Med 2004, 21:657-665.
5. Bry L., Chen P.C., Sacks D.B. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001, 47:153-163.
6. Koga M., Kasayama S. Clinical usefulness of glycated albumin as an another glycemic control marker. Endocr J 2010, 57:751-762.
7. Okada T., Nakao T., Matsumoto H., et al. Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease. Intern Med 2011, 50:23-29.
8. Koga M., Murai J., Saito H., Matsumoto S., Kasayama S. Effect of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects. Diabetes Res Clin Pract 2009, 84:163-167.
9. Koga M., Kasayama S., Kanehara H., Bando Y. CLD (chronic liver disease)-HbA1c as a novel indicator for estimation of mean plasma glucose in the patients with chronic liver disease. Diabetes Res Clin Pract 2008, 81:258-262.
10. Arnaldi G., Angeli A., Atkinson A.B., et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2003, 88:5593-5602.
11. Etxabe J., Vazquez J.A. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) 1994, 40:479-484.
12. Mancini T., Kola B., Mantero F., Boscaro M., Arnaldi G. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol (Oxf) 2004, 61:768-777.
13. Simmons P.S., Miles J.M., Gerich J.E., Haymond M.W. Increased proteolysis. An effect of increases in plasma cortisol within the physiologic range. J Clin Invest 1984, 73:412-420.
14. Burt M.G., Gibney J., Ho K.K. Protein metabolism in glucocorticoid excess: study in Cushing's syndrome and the effect of treatment. Am J Physiol Endocrinol Metab 2007, 292:E1426-E1432.
15. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
16. Rohlfing C.L., Wiedmeyer H.M., Little R.R., England J.D., Tennill A., Goldstein D.E. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the diabetes control and complications trial. Diabetes Care 2002, 25:275-278.
17. Ogawa A., Hayashi A., Kishihara E., Yoshino S., Takeuchi A., Shichiri M. New indices for predicting glycaemic variability. PLoS One 2012, 7:e46517.
18. Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol Int 2012, 3:8-10.
19. Kouzuma T., Usami T., Yamakoshi M., Takahashi M., Imamura S. An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chim Acta 2002, 324:61-71.
20. Kohzuma T., Koga M. Lucica GA-L glycated albumin assay kit: a new diagnostic test for diabetes mellitus. Mol Diagn Ther 2010, 14:49-51.
21. Brambell F.W.R., Hemmings W.A., Morris I.G. A theoretical model of gamma-globulin catabolism. Nature 1964, 203:1352-1355.
22. Junghans R.P., Anderson C.L. The protection receptor for IgG catabolism is the, β2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci U S A 1996, 93:5512-5516.
23. Chaudhury C., Mehnaz S., Robinson J.M., et al. The major histocompatibility complex-related Fc Receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 2003, 197:315-322.
24. Waldmann T.A., Terry W.D. Familial hypercatabolic hypoproteinemia: a disorder of endogenous catabolism of albumin and immunoglobulin. J Clin Invest 1990, 86:2093-2098.
25. Wani M.A., Haynes L.D., Kim J., et al. Familial hypercatabolic hypoproteinemia causedby deficiency of the neonatal Fc receptor, FcRn, due to a mutant β2-microglobulin gene. Proc Natl Acad Sci U S A 2006, 103:5084-5089.
26. Griffin P., Wild A.E. Effect of dexamethasone on Fc gamma receptor expression in foetal and neonatal rat gut. Experientia 1988, 44:242-245.
27. Kim K.J., Fandy T.E., Lee V.H., Ann D.K., Borok Z., Crandall E.D. Net absorption of IgG via FcRn-mediated transcytosis across rat alveolar epithelial cell monolayers. Am J Physiol Lung Cell Mol Physiol 2004, 287:L616-L622.
28. Yamanouchi T., Sekino N., Yoshimura T., et al. Acute glucosuria after continuous glucocorticoid loading in the rat in vivo. Eur J Pharmacol 1998, 341:257-263.